Strategic B2B Sourcing for African Pharmaceutical Importers, Wholesalers & Diabetes Care Centers Sky High Medex is a specialized pharmaceutical exporter providing Dapaworth 10mg Tablets to licensed medical wholesalers, institutional procurement groups, and specialized endocrinology clinics across the African Continent. Manufactured by Ethinext Pharma, Dapaworth contains Dapagliflozin, an advanced SGLT2 inhibitor utilized in professional clinical settings to manage Type 2 diabetes and provide cardiorenal protection.
B2B Order Details:
Minimum Order Quantity (MOQ): 500 Tablets (Strictly Wholesale).
Active Ingredient: Dapagliflozin 10mg.
Manufacturer: Ethinext Pharma.
Therapeutic Class: SGLT2 Inhibitor; Antidiabetic & Cardioprotective Agent.
Format: Film-Coated Tablet.
The Sky High Medex Advantage for the African Market:
Direct Export Economies: Optimize procurement margins for healthcare networks in South Africa, Nigeria, Kenya, Egypt, and Ghana by sourcing directly from our Indian wholesale center, offering high cost-efficiency for chronic care medications.
Ethinext Pharma Quality: Access a reliable formulation produced under strict quality controls, ensuring the bioequivalence and chemical stability required for consistent therapeutic outcomes.
Verified Export Authority: We operate with a valid Import-Export Code (IEC) and GST registration, offering a 100% transparent and professional trade trail for African-based corporate and medical entities.
Full Documentation Suite: Every shipment is accompanied by a Certificate of Analysis (COA), detailed commercial invoices, and packing lists to support regional regulatory compliance and inventory auditing.
Logistics & African Regional Support: While domestic customs clearance and adherence to national health authorities (such as SAHPRA in South Africa or NAFDAC in Nigeria) remain the responsibility of the importer, Sky High Medex ensures all Indian export formalities are handled with professional precision. We offer reliable air-freight shipping to major African air hubs, including Johannesburg (JNB), Nairobi (NBO), and Lagos (LOS).
Technical Insight & Pharmacological Action: Dapaworth (Dapagliflozin) is recognized for its unique non-insulin-dependent mechanism. In a clinical and research context, it is noted for:
Mechanism of Action: By inhibiting the Sodium-Glucose Cotransporter 2 (SGLT2) protein in the kidneys, Dapagliflozin reduces the reabsorption of glucose into the bloodstream. This promotes the excretion of excess glucose through urine, effectively lowering blood sugar levels.
Cardiorenal Benefits: Beyond glycemic control, it is increasingly utilized to reduce the risk of cardiovascular death and hospitalization in patients with heart failure and to slow the progression of chronic kidney disease (CKD).
Pharmacokinetic Profile: Following oral administration, the active ingredient is rapidly absorbed, reaching peak plasma concentrations within 2 hours. It offers a consistent 24-hour therapeutic window with once-daily dosing.
Storage Stability: Formulated to maintain integrity across various climates, making it suitable for distribution throughout diverse geographical regions.
👉
📦 Request a Wholesale Quote for Africa Direct B2B support for African-based pharmaceutical buyers and healthcare distributors.
WhatsApp: +91 9270847472
Email: skyhighmedex@gmail.com
Location: Nagpur Export Hub / International Service Desk
